Recent Insider Transactions - InMed Pharmaceuticals (NASDAQ: INM)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ INM InMed Pharmaceuticals

HULL ANDREW / director

01/14/2024

Sell

$307.01

$13K

8,542

NASDAQ INM InMed Pharmaceuticals

HSU ERIC C / officer: Sr. VP, Pre-Clinical Res/Dev

03/04/2024

Sell

$364.72

309

$113K

52,545

NASDAQ INM InMed Pharmaceuticals

MANCINI ALEXANDRA DIANE JANET / officer: Sr VP, Clinical Reg Affairs

01/21/2024

Sell

$312.73

121

$38K

52,485

NASDAQ INM InMed Pharmaceuticals

Jagpal Netta / officer: Chief Financial Officer

02/20/2024

Sell

$0.37

50,000

$19K

NASDAQ INM InMed Pharmaceuticals

HULL ANDREW / director

02/21/2024

Buy

$0.39

37,500

$15K

38,258

NASDAQ INM InMed Pharmaceuticals

ADAMS ERIC A / director, officer: President & CEO

02/20/2024

Buy

$0.36

41,600

$15K

43,959

NASDAQ INM InMed Pharmaceuticals

Johnson Shane Aaron / officer: Sr VP & General Manager

12/23/2023

Buy

$0.37

40,000

$15K

48,000

NASDAQ INM InMed Pharmaceuticals

Lemerond Nicole / director

12/23/2023

Buy

$0.37

7,100

$3K

8,500

NASDAQ INM InMed Pharmaceuticals

WOUDENBERG MICHAEL / officer: Chief Operating Officer

12/23/2023

Buy

$0.37

65,000

$24K

75,494

NASDAQ INM InMed Pharmaceuticals

Tegge Jonathan / officer: Interim CFO

12/23/2023

Buy

$0.37

30,000

$11K

31,400

NASDAQ INM InMed Pharmaceuticals

Grove Janet P / director

12/23/2023

Buy

$0.37

7,100

$3K

8,500

NASDAQ INM InMed Pharmaceuticals

HSU ERIC C / officer: Sr. VP, Pre-Clinical Res/Dev

12/23/2023

Buy

$0.37

45,000

$17K

52,854

NASDAQ INM InMed Pharmaceuticals

ADAMS ERIC A / director, officer: President & CEO

12/23/2023

Buy

$0.37

136,000

$50K

162,139

NASDAQ INM InMed Pharmaceuticals

Baldasare Bryan T / director

12/23/2023

Buy

$0.37

7,100

$3K

8,500

NASDAQ INM InMed Pharmaceuticals

MANCINI ALEXANDRA DIANE JANET / officer: Sr VP, Clinical Reg Affairs

12/23/2023

Buy

$0.37

45,000

$17K

52,606

NASDAQ INM InMed Pharmaceuticals

HULL ANDREW / director

12/23/2023

Buy

$0.37

7,100

$3K

8,584

NASDAQ INM InMed Pharmaceuticals

WOUDENBERG MICHAEL / officer: Chief Operating Officer

12/05/2023

Sell

$270.36

848

$229K

10,494

NASDAQ INM InMed Pharmaceuticals

HSU ERIC C / officer: Sr. VP, Pre-Clinical Res/Dev

08/31/2023

Sell

$499.96

327

$163K

7,854

NASDAQ INM InMed Pharmaceuticals

HSU ERIC C / officer: Sr. VP, Pre-Clinical Res/Dev

05/16/2023

Sell

$623.93

152

$95K

8,181

NASDAQ INM InMed Pharmaceuticals

MANCINI ALEXANDRA DIANE JANET / officer: Sr VP, Clinical Reg Affairs

05/16/2023

Sell

$623.93

485

$303K

7,606

NASDAQ INM InMed Pharmaceuticals

ADAMS ERIC A / director, officer: President & CEO

05/16/2023

Sell

$623.93

1,818

$1.134M

26,139

NASDAQ INM InMed Pharmaceuticals

MANCINI ALEXANDRA DIANE JANET / officer: Sr VP, Clinical Reg Affairs

03/08/2023

Sell

$927.64

$57K

8,091

NASDAQ INM InMed Pharmaceuticals

HSU ERIC C / officer: Sr. VP, Pre-Clinical Res/Dev

03/08/2023

Sell

$927.64

545

$506K

8,333

NASDAQ INM InMed Pharmaceuticals

ADAMS ERIC A / director, officer: President & CEO

03/08/2023

Sell

$927.64

545

$506K

27,957

NASDAQ INM InMed Pharmaceuticals

Li Sarah / officer: VP, Accounting and Controller

11/16/2022

Sell

$35.00

$3K

NASDAQ INM InMed Pharmaceuticals

MANCINI ALEXANDRA DIANE JANET / officer: Sr VP, Clinical Reg Affairs

06/02/2022

Sell

$11.75

1,515

$18K

98,787

NASDAQ INM InMed Pharmaceuticals

Baldasare Bryan T / director

05/17/2022

Sell

$0.80

14,000

$11K

14,000